AngioDynamics Q3 Fiscal 2026 Financial Overview
Company Overview AngioDynamics is a medical technology company focused on restoring vascular blood flow, expanding cancer treatments, and improving patient ...
Monday, April 6, 2026
Tag: AngioDynamics
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of ...
Earnings Summary: AngioDynamics (ANGO) reports Q1 loss; sales up 12.2%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.